GlaxoSmithKline Scientists Accused of Stealing Trade Secrets
- U.S. says they tried to sell secrets through China company
- Scheme targeted cancer treatments, federal prosecutors say
This article is for subscribers only.
U.S. prosecutors accused two scientists working for GlaxoSmithKline Plc of scheming with three others to steal the company’s trade secrets for cancer drugs.
Yu Xue, 45, and Lucy Xi, 38, who worked at Glaxo’s research facility in Upper Merion, Pennsylvania, plotted to market and sell the stolen biopharmaceutical secrets through a company in China called Renopharma, Philadelphia U.S. Attorney Zane Memeger said Wednesday.